- Home
- POAI vs SNOA Comparison
POAI vs SNOA Comparison
Compare POAI & SNOA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- POAI
- SNOA
- Stock Information
- Founded
- POAI 2002
- SNOA 1999
- Country
- POAI United States
- SNOA United States
- Employees
- POAI N/A
- SNOA N/A
- Industry
- POAI Industrial Specialties
- SNOA Biotechnology: Pharmaceutical Preparations
- Sector
- POAI Health Care
- SNOA Health Care
- Exchange
- POAI Nasdaq
- SNOA Nasdaq
- Market Cap
- POAI 7.8M
- SNOA 6.4M
- IPO Year
- POAI N/A
- SNOA 2007
- Fundamental
- Price
- POAI $0.85
- SNOA $3.06
- Analyst Decision
- POAI Hold
- SNOA
- Analyst Count
- POAI 1
- SNOA 0
- Target Price
- POAI N/A
- SNOA N/A
- AVG Volume (30 Days)
- POAI 168.6K
- SNOA 52.3K
- Earning Date
- POAI 08-19-2025
- SNOA 08-07-2025
- Dividend Yield
- POAI N/A
- SNOA N/A
- EPS Growth
- POAI N/A
- SNOA N/A
- EPS
- POAI N/A
- SNOA N/A
- Revenue
- POAI $1,729,269.00
- SNOA $14,912,000.00
- Revenue This Year
- POAI $486.27
- SNOA $23.00
- Revenue Next Year
- POAI $65.50
- SNOA $24.59
- P/E Ratio
- POAI N/A
- SNOA N/A
- Revenue Growth
- POAI 24.17
- SNOA 17.43
- 52 Week Low
- POAI $0.55
- SNOA $1.75
- 52 Week High
- POAI $3.06
- SNOA $5.93
- Technical
- Relative Strength Index (RSI)
- POAI 47.32
- SNOA 41.95
- Support Level
- POAI $0.71
- SNOA $2.91
- Resistance Level
- POAI $0.82
- SNOA $3.16
- Average True Range (ATR)
- POAI 0.05
- SNOA 0.20
- MACD
- POAI 0.00
- SNOA -0.03
- Stochastic Oscillator
- POAI 63.73
- SNOA 24.43
About POAI Predictive Oncology Inc.
Predictive Oncology Inc functions in the healthcare domain. The firm's reportable segments are Pittsburgh segment that provides services which include the application of AI using its proprietary biobank of 150,000+ tumor samples. It also creates proprietary 3D culture models used in drug development; Birmingham segment that provides contract services and research focused on solubility improvements, stability studies, and protein production; and Eagan segment that produces the FDA-cleared STREAMWAY System and associated products for automated medical fluid waste management and patient-to-drain medical fluid disposal. It derives maximum revenue from Eagan Segment.
About SNOA Sonoma Pharmaceuticals Inc.
Sonoma Pharmaceuticals Inc is a specialty pharmaceutical company operating in the United States. It is engaged in identifying, developing, and commercializing differentiated therapies for patients living with chronic skin conditions. The company focuses on the development and commercialization of therapeutic solutions in medical dermatology to treat skin conditions, such as acne, atopic dermatitis, and scarring. The key products of the company are Celacyn, Ceramax Skin Barrier Cream, Mondoxyne, Alevicyn, SebuDerm, Microcyn, and Microcyn which are available for various skin treatments such as scars, itchy skin, minor skin irritations, rashes, and others. The company derives revenue from the sale of products in the United States, Latin America, Europe, Asia, and other countries.